PERIACTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Periactin, and what generic alternatives are available?
Periactin is a drug marketed by Merck and is included in two NDAs.
The generic ingredient in PERIACTIN is cyproheptadine hydrochloride. There are six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the cyproheptadine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Periactin
A generic version of PERIACTIN was approved as cyproheptadine hydrochloride by CHARTWELL RX on May 26th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PERIACTIN?
- What are the global sales for PERIACTIN?
- What is Average Wholesale Price for PERIACTIN?
Summary for PERIACTIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Clinical Trials: | 6 |
| Patent Applications: | 3,752 |
| DailyMed Link: | PERIACTIN at DailyMed |
Recent Clinical Trials for PERIACTIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Kinnov Therapeutics | Phase 1 |
| Rehabilitation Institute of Chicago | N/A |
| National Institutes of Health (NIH) | N/A |
US Patents and Regulatory Information for PERIACTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | PERIACTIN | cyproheptadine hydrochloride | SYRUP;ORAL | 013220-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | PERIACTIN | cyproheptadine hydrochloride | TABLET;ORAL | 012649-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
